Ann Intern Med

1. ANDREWS RA, Erickson SM, Goldman JM, Moyer DV, et al
   Deja Flu All Over Again: The Risk for Overwhelm of the U.S. Health Care System by Vaccine-Preventable and Modifiable Diseases.
   Ann Intern Med. 2025 Sep 30. doi: 10.7326/ANNALS-25-03999.
   

   >> Share

   
   

   
   Arch Virol

2. CUI X, Wang S, Han Q, Jin N, et al
   Molecular characterization of infectious laryngotracheitis virus in China and host transcriptomic responses to immunization with a live attenuated vaccine.
   Arch Virol. 2025;170:216.
   

   >> Share

   
   

   
   BMJ

3. YANG YT
   Rethinking the narrative on vaccine policy and public trust.
   BMJ. 2025;390:r1952.
   

   >> Share

   
   
4. DYER O
   Covid vaccines: How is policy changing in the US and UK?
   BMJ. 2025;390:r2040.
   

   >> Share

   
   
5. LANG K
   Trump's claims on Tylenol (paracetamol), vaccines, and autism-what's the truth?
   BMJ. 2025;390:r2025.
   

   >> Share

   
   

   
   Clin Infect Dis

6. CARAZO S, Phimmasone J, Skowronski DM, Giguere K, et al
   Effectiveness of COVID-19 vaccination and prior infections to reduce long COVID risk during the pre-Omicron and Omicron periods.
   Clin Infect Dis. 2025 Sep 29:ciaf549. doi: 10.1093.
   

   >> Share

   
   

   
   J Immunol

7. KRUEGER PD, Osum KC, Fife BT, Jenkins MK, et al
   Foreign epitope-specific regulatory T cells respond robustly to vaccination and limit Th1 differentiation by conventional T cells specific for the same epitope.
   J Immunol. 2025 Sep 27:vkaf254. doi: 10.1093.
   

   >> Share

   
   

   
   J Virol

8. PAN Z, Jiang L, Chen Y, Peng H, et al
   Adjuvant-dependent protection of SARS-CoV-2 spike vaccines: comparative immunogenicity of human-applicable formulations.
   J Virol. 2025 Oct 3:e0109925. doi: 10.1128/jvi.01099.
   

   >> Share

   
   
9. SUN L, Huang M, Feng S, Zhang W, et al
   Developing an eVLP mRNA vaccine for respiratory syncytial virus with enhanced pre-fusion targeting humoral responses.
   J Virol. 2025 Sep 30:e0120925. doi: 10.1128/jvi.01209.
   

   >> Share

   
   

   
   JAMA

10. LOTSCHER J, Walti CS, Heller S, Hengy Linder F, et al
    Respiratory Syncytial Virus Vaccination in Adult Allogeneic Hematopoietic Cell Transplant Recipients.
    JAMA. 2025 Oct 2:e2516744. doi: 10.1001/jama.2025.16744.
    

    >> Share

    
    
11. VERMUND SH
    Potential Repercussions of Eliminating Mandatory Vaccination in Florida.
    JAMA. 2025 Oct 1. doi: 10.1001/jama.2025.19510.
    

    >> Share

    
    
12. NAVIN MC, Ross LF
    America's Vaccine Policy Whiplash-Finding the Way Forward.
    JAMA. 2025 Oct 1. doi: 10.1001/jama.2025.19088.
    

    >> Share

    
    
13. ANDERER S
    Updated COVID-19 Vaccine Generates Strong Immune Response.
    JAMA. 2025 Sep 26. doi: 10.1001/jama.2025.13887.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

14. FAZAL A, Harker EJ, Neelam V, Olson SM, et al
    Pediatric Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy - United States, 2024-25 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2025;74:556-564.
    

    >> Share

    
    
15. REINHART K, Huang S, Kniss K, Reed C, et al
    Influenza-Associated Pediatric Deaths - United States, 2024-25 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2025;74:565-569.
    

    >> Share

    
    
16. RUSS S, Nogareda F, Regan AK, Benedetti E, et al
    Interim Effectiveness Estimates of 2025 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Outpatient and Hospitalized Illness - Eight Southern Hemisphere Countries, March-September 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:570-578.
    

    >> Share

    
    

    
    Pediatr Infect Dis J

17. HOMINAL A, Gualtieri R, Lemaitre B, Posfay-Barbe KM, et al
    Vaccine Immunity Against Pneumococcus in Children With Cochlear Implants.
    Pediatr Infect Dis J. 2025 Sep 26. doi: 10.1097/INF.0000000000004999.
    

    >> Share

    
    

    
    PLoS Comput Biol

18. 
    Correction: Design of field trials for the evaluation of transmissible vaccines in animal populations.
    PLoS Comput Biol. 2025;21:e1013530.
    

    >> Share

    
    

    
    PLoS One

19. TOGEL J, Kuhbandner C
    COVID-19 vaccinations among German university students: The role of fear of COVID-19 and risk assessment.
    PLoS One. 2025;20:e0333082.
    

    >> Share

    
    
20. CHEMAITELLY H, Ayoub HH, Coyle P, Tang P, et al
    Evaluating the cost-effectiveness of COVID-19 mRNA primary-series vaccination in Qatar: An integrated epidemiological and economic analysis.
    PLoS One. 2025;20:e0331654.
    

    >> Share

    
    
21. FORTUNATO P, Lombini A
    Behind political affiliation: How moral values, identity politics, and party loyalty have affected COVID-19 vaccination.
    PLoS One. 2025;20:e0330881.
    

    >> Share

    
    
22. JORDAN S, Bottger SJ, Zinn S
    The persuasiveness of different sources of information on the decision to vaccinate. A cross-sectional study in Germany during the pandemic at the turn of the year 2021/2022.
    PLoS One. 2025;20:e0333268.
    

    >> Share

    
    
23. SEFAH IA, Ofori P, Hutton-Nyameaye A, Yamoah P, et al
    COVID-19 vaccine hesitancy and its predictors among healthcare workers in a tertiary hospital in Ghana: A cross-sectional survey.
    PLoS One. 2025;20:e0333412.
    

    >> Share

    
    
24. KUMAR D, Sagar V, Kujur A, Bhardwaj S, et al
    Identifying key predictors amongst children of under 5 years of age with fever and rashes amidst measles outbreak in Jharkhand: A case control study.
    PLoS One. 2025;20:e0333381.
    

    >> Share

    
    
25. CHAUFAN C
    How did Ontario healthcare institutions implement and legitimize Covid-19 vaccine mandates? A qualitative multi?method study protocol.
    PLoS One. 2025;20:e0332589.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

26. VILLAREJO-TORRES M, Nombela-Diaz I, Munoz-Santos D, Ruiz-Yuste M, et al
    SARS-CoV-2-derived RNA replicons as safe and effective vaccines.
    Proc Natl Acad Sci U S A. 2025;122:e2516587122.
    

    >> Share

    
    
27. MORIYAMA M, Rodrigues G, Wang J, Jayewickreme R, et al
    Intranasal hemagglutinin protein boosters induce protective mucosal immunity against influenza A viruses in mice.
    Proc Natl Acad Sci U S A. 2025;122:e2422171122.
    

    >> Share

    
    
28. REUBER EE, Hickey E, Pradhan A, Sprute R, et al
    Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development.
    Proc Natl Acad Sci U S A. 2025;122:e2505340122.
    

    >> Share

    
    
29. LV H, Teo QW, Pholcharee T, Liu W, et al
    Molecular divergence and convergence of mammalian antibody responses to the influenza virus hemagglutinin stem.
    Proc Natl Acad Sci U S A. 2025;122:e2510927122.
    

    >> Share

    
    

    
    Vaccine

30. FANG X, Holding AC, Audet EC, Thai H, et al
    Understanding COVID-19 vaccination disparity among Black adults in North America: A two-study motivational approach.
    Vaccine. 2025;65:127803.
    

    >> Share

    
    
31. WROBLEWSKI M, Meler A
    Vaccine acceptance and refusal in Western and Central and Eastern European countries: An analysis based on the European Social Survey data from 23 countries, using a classification and regression tree.
    Vaccine. 2025;65:127807.
    

    >> Share

    
    
32. CLARKE M, McMillan M, Giles LC, Riley K, et al
    The impact of obesity on influenza Vaccine immunogenicity: A systematic review.
    Vaccine. 2025;65:127794.
    

    >> Share

    
    
33. DOMINGUEZ ISLAS CP, Magaret CA, Molitor C, Serebryannyy L, et al
    SARS-CoV-2 spike sequence-based distance as a marker of binding antibody response to COVID-19 vaccines.
    Vaccine. 2025;65:127738.
    

    >> Share

    
    
34. ZHANG CX, Quigley MA, Bankhead C, Varughese R, et al
    Ethnic inequities in childhood influenza vaccination coverage in England 2013-2021: An observational cohort study.
    Vaccine. 2025;65:127710.
    

    >> Share

    
    
35. CAMPBELL PM, Ess GJ, Lale A, Talaat KR, et al
    Clinical immunization safety assessment (CISA) project: COVID-19 vaccine consultations and case reviews.
    Vaccine. 2025;65:127781.
    

    >> Share

    
    
36. NOEL A, Zhang J, Nedumpun T, Sitthicharoenchai P, et al
    T cell-mediated clearance of porcine reproductive and respiratory syndrome virus (PRRSV) from the lung characterized by machine learning analysis in vaccinated and unvaccinated pigs.
    Vaccine. 2025;65:127793.
    

    >> Share

    
    
37. CHAUDHRY T, Tum P, Morrow F, Hargreaves S, et al
    Facilitators to strengthening vaccine uptake post-pandemic amongst underserved populations considering social norms and health beliefs: a global systematic review.
    Vaccine. 2025;65:127769.
    

    >> Share

    
    
38. CAO X, Borah P, Lee DKL, Vishnevskaya A, et al
    Beyond the post: The impact of politized anti-vaccine misinformation comments and challenges of correction on social media.
    Vaccine. 2025;65:127760.
    

    >> Share

    
    
39. ZEEVAT F, Luttjeboer J, Korsten K, van Boven M, et al
    Evaluating cost-effectiveness of RSV vaccination strategies for older adults in the Netherlands.
    Vaccine. 2025;65:127735.
    

    >> Share

    
    
40. ROSENBLUM HG, Carpenter CM, Trosclair T, Kaul R, et al
    Time intervals from vaccine administration to reimbursement for an updated Advisory Committee on Immunization Practices (ACIP) recommendation: Evidence from pneumococcal conjugate vaccinations among privately insured adults, 2021-2022.
    Vaccine. 2025;64:127665.
    

    >> Share

    
    
41. SCHUE JL, Miller ES, Fesshaye B, Singh P, et al
    Corrigendum to "COVID-19 vaccine attitudes, beliefs, intentions and behaviors among pregnant women within the context of dynamic national policy recommendations in Brazil, Ghana, Kenya, and Pakistan" [Vaccine (2025) 127595].
    Vaccine. 2025 Sep 25:127768. doi: 10.1016/j.vaccine.2025.127768.
    

    >> Share

    
    
42. VAN SCHALKWYK C, Meyer-Rath G, Masuku S, Jamieson L, et al
    Cost-effectiveness of different HPV vaccination strategies for cervical cancer prevention in South Africa.
    Vaccine. 2025;64:127770.
    

    >> Share

    
    
43. CHO H, Jeong NY, Kim HJ, Lee HE, et al
    Intussusception risk after rotavirus vaccination in Korean infants.
    Vaccine. 2025;64:127782.
    

    >> Share

    
    
44. HWANG LE, Lin KY, Tseng PH, Ho SY, et al
    Impact of 10-year measles, mumps and rubella booster vaccination program among healthcare personnel: a cross-sectional study.
    Vaccine. 2025;64:127758.
    

    >> Share

    
    
45. VAN RIJN PA, Wernery U, Feddema AJ, Maris-Veldhuis MA, et al
    Development of African horse sickness disabled infectious single animal (DISA)-DIVA vaccine platform applied for all nine serotypes.
    Vaccine. 2025;64:127772.
    

    >> Share

    
    
46. PRZEDPELSKI A, Tepp WH, Gupta S, Barbieri JT, et al
    Nontoxic, multi-domain botulinum neurotoxin-LCHC(N) as vaccines against botulism.
    Vaccine. 2025;65:127779.
    

    >> Share

    
    
47. YANG Z, Zhang S, Zhao Y, Ma X, et al
    A mosaic H3 subtype live attenuated influenza vaccine elicits broad immune responses to influenza a viruses.
    Vaccine. 2025;65:127776.
    

    >> Share

    
    
48. ANWARI P, Sume G, Meshreky W, Maele NV, et al
    Health economics and vaccine financing in the eastern Mediterranean region: A needs assessment.
    Vaccine. 2025;65:127780.
    

    >> Share

    
    
49. BREZNIK JA, Miller MS, Bowdish DME
    Rationalizing recommendations for influenza and COVID-19 vaccines.
    Vaccine. 2025;65:127775.
    

    >> Share

    
    

    
    Virology

50. QIAO Y, Tang M, Du M, Zhao C, et al
    H5N1 influenza virus-like particles based on BEVS induce robust functional antibodies and immune responses.
    Virology. 2025;612:110672.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share